Annals of Oncology

Editorials:

J. P. Donnelly, N. M. A. Blijlevens, and C. A. H. Verhagen

Can anything be done about oral mucositis?
Ann Oncol 14: 505-507; doi:10.1093/annonc/mdg179
[Extract] [FREE Full Text] [PDF] [Request Permissions]

L. Licitra

Chemoradiation therapy in locally advanced nasopharyngeal cancer: which kind of cooperation?
Ann Oncol 14: 508-509; doi:10.1093/annonc/mdg180
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

D. Cella, D. Dobrez, and J. Glaspy

Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes
Ann Oncol 14: 511-519; doi:10.1093/annonc/mdg167
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Boye, T. Elter, and A. Engert

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Ann Oncol 14: 520-535; doi:10.1093/annonc/mdg175
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Breast cancer:

D. Pectasides, M. Pectasides, D. Farmakis, N. Bountouroglou, M. Nikolaou, M. Koumpou, N. Mylonakis, and C. Kosmas

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
Ann Oncol 14: 537-542; doi:10.1093/annonc/mdg172
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. A. Gelmon, T. A. Vandenberg, L. Panasci, B. Norris, M. Crump, L. Douglas, W. Walsh, S. J. Matthews, and L. K. Seymour

A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129
Ann Oncol 14: 543-548; doi:10.1093/annonc/mdg171
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. A. Daly, C. Nolan, A. Green, W. Ormiston, N. Cody, T. McDevitt, B. O’hIci, D. Byrne, E. McDermott, D. N. Carney, N. O’Higgins, and D. E. Barton

Predictive testing for BRCA1 and 2 mutations: a male contribution
Ann Oncol 14: 549-553; doi:10.1093/annonc/mdg164
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

N. Kröger, A. R. Zander, G. Martinelli, P. Ferrante, J. M. Moraleda, G. A. Da Prada, T. Demirer, G. Socie, and G. Rosti

Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation
Ann Oncol 14: 554-558; doi:10.1093/annonc/mdg161
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Supportive care:

C. Dazzi, A. Cariello, P. Giovanis, M. Monti, B. Vertogen, M. Leoni, A. Tienghi, D. Turci, G. Rosti, O. Nanni, C. Rondoni, and M. Marangolo

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study
Ann Oncol 14: 559-563; doi:10.1093/annonc/mdg177
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Head and neck cancer:

J. L. Oh, E. E. Vokes, M. S. Kies, B. B. Mittal, M. E. Witt, R. R. Weichselbaum, and D. J. Haraf

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
Ann Oncol 14: 564-569; doi:10.1093/annonc/mdg163
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

R. D. James, N. Botwood, C. C. Vernon, and P. Price

Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study
Ann Oncol 14: 570-573; doi:10.1093/annonc/mdg165
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Kralidis, S. Aebi, H. Friess, M. W. Büchler, and M. M. Borner

Activity of raltitrexed and gemcitabine in advanced pancreatic cancer
Ann Oncol 14: 574-579; doi:10.1093/annonc/mdg150
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. R. Alberts, P. M. Townley, R. M. Goldberg, S. S. Cha, D. J. Sargent, D. F. Moore, J. E. Krook, H. C. Pitot, T. R. Fitch, M. Wiesenfeld, and J. A. Mailliard

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study
Ann Oncol 14: 580-585; doi:10.1093/annonc/mdg170
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Panzuto, M. Falconi, S. Nasoni, S. Angeletti, A. Moretti, M. Bezzi, G. Gualdi, E. Polettini, R. Sciuto, A. Festa, F. Scopinaro, V. D. Corleto, C. Bordi, P. Pederzoli, and G. Delle Fave

Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy
Ann Oncol 14: 586-591; doi:10.1093/annonc/mdg160
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

P. Morice, S. Camatte, A. Rey, D. Atallah, C. Lhommé, P. Pautier, C. Pomel, J.-F. Coté, C. Haie-Meder, P. Duvillard, and D. Castaigne

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary
Ann Oncol 14: 592-598; doi:10.1093/annonc/mdg173
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Brain tumors:

M. J. van den Bent, O. Chinot, W. Boogerd, J. Bravo Marques, M. J. B. Taphoorn, J. M. Kros, C. C. D. van der Rijt, C. J. Vecht, N. De Beule, and B. Baron

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972
Ann Oncol 14: 599-602; doi:10.1093/annonc/mdg157
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Raymond, M. Fabbro, V. Boige, O. Rixe, M. Frenay, G. Vassal, S. Faivre, E. Sicard, C. Germa, J. M. Rodier, L. Vernillet, and J. P. Armand

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
Ann Oncol 14: 603-614; doi:10.1093/annonc/mdg159
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

C. Dumontet, J. Jaubert, C. Sebban, F. Bouafia, C. Ardiet, B. Tranchand, E. Berger, C. Lucas, D. Guyotat, and B. Coiffier

Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients
Ann Oncol 14: 615-622; doi:10.1093/annonc/mdg158
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Damaj, V. Verkarre, A. Delmer, P. Solal-Celigny, I. Yakoub-Agha, C. Cellier, F. Maurschhauser, R. Bouabdallah, V. Leblond, F. Lefrère, D. Bouscary, J. Audouin, B. Coiffier, B. Varet, T. Molina, N. Brousse, and O. Hermine

Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review
Ann Oncol 14: 623-629; doi:10.1093/annonc/mdg168
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

J. Bennouna, P. Fumoleau, J.-P. Armand, E. Raymond, M. Campone, F.-M. Delgado, C. Puozzo, and M. Marty

Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours
Ann Oncol 14: 630-637; doi:10.1093/annonc/mdg174
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

V. Hess, M. W. Verrill, C. C. Bomphray, M. M. Vaughan, M. Allen, and M. E. Gore

Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma
Ann Oncol 14: 638-642; doi:10.1093/annonc/mdg176
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. C. Etienne, F. Leger, X. Pivot, E. Chatelut, R. J. Bensadoun, E. Guardiola, N. Renée, N. Magné, P. Canal, and G. Milano

Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance
Ann Oncol 14: 643-647; doi:10.1093/annonc/mdg162
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

D. Forman, D. Stockton, H. Møller, M. Quinn, P. Babb, R. De Angelis, and A. Micheli

Cancer prevalence in the UK: results from the EUROPREVAL study
Ann Oncol 14: 648-654; doi:10.1093/annonc/mdg169
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

M. Spina, A. Re, E. Vaccher, J. Gabarre, and U. Tirelli

High international prognostic score predicts a worse outcome for patients with Hodgkin’s disease and HIV infection: results of a prospective study with Stanford V regimen
Ann Oncol 14: 655-656; doi:10.1093/annonc/mdg152
[Extract] [FREE Full Text] [PDF] [Request Permissions]

C. M. L. da Costa, A. Lopes, and B. de Camargo

A simple cost-effective lactate dehydrogenase level measurement can stratify patients with Ewing’s tumor into low and high risk
Ann Oncol 14: 656; doi:10.1093/annonc/mdg151
[Extract] [FREE Full Text] [PDF] [Request Permissions]

J. L. Villano, A. M. Mauer, and E. E. Vokes

A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain
Ann Oncol 14: 656-658; doi:10.1093/annonc/mdg153
[Extract] [FREE Full Text] [PDF] [Request Permissions]

B. Meyer, W. Hagen, W. Scheithauer, L. Öhler, and G. V. Kornek

L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphoma
Ann Oncol 14: 658-659; doi:10.1093/annonc/mdg154
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. A. Wright, B. Schuler, E. Szabo, and J. L. Grem

Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin
Ann Oncol 14: 659-660; doi:10.1093/annonc/mdg155
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

F. R. Hirsch

B. Driscoll (ed). Lung Cancer. Volume II: Diagnostic and Therapeutic Methods and Reviews
Ann Oncol 14: 661; doi:10.1093/annonc/mdg156
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Biondi

P.A. Pizzo, D.G. Poplack (eds). Principles and Practice of Pediatric Oncology
Ann Oncol 14: 661-662; doi:10.1093/annonc/mdg166
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.